<p>作者：Genna Contino</p>
<p>随着一种新的减肥药丸和高剂量注射剂进入市场，价格已降至原价的一小部分</p>
<p>GLP-1 药物现在有注射剂和药丸形式，但如何支付这些药物的费用可能会变得复杂。</p>
<p>以前，使用 GLP-1 药物意味着每月注射一次，费用高达 1000 美元。如今，想要使用这种广受欢迎的减肥药物的患者可以选择不同类型的注射剂甚至药丸，现金折扣价格低至 149 美元。</p>
<p>减肥药物市场仍在扩张。制药公司诺和诺德（Novo Nordisk）周二宣布，其 Wegovy 注射剂的更高剂量现在在美国上市，成为市场上的另一个选择，仅在食品和药物管理局批准竞争对手礼来的（Eli Lilly）减肥药 Foundayo 一周后。</p>
<p>如何支付这些药物的费用可能很复杂，这也是消费者面临的一个关键问题，因为医疗费用和保险费飙升。</p>
<p>根据 KFF 的健康福利调查，2025 年，拥有 200 名或更多员工的公司提供的商业保险计划中，仅有 19% 计划覆盖 GLP-1 减肥药物，而且即使覆盖，通常也会附带限制。这意味着许多患者被迫自费或寻找制造商优惠券以减轻费用负担。</p>
<p>阅读更多：新的高剂量 Wegovy 的价格低于 Zepbound</p>
<p>医疗分析师表示，诺和诺德在为自费患者提供可负担的肥胖治疗选择方面做出了最大努力，部分原因是礼来的药物市场份额最大，但两家公司药物的价格点大致相似。随着新选择的出现，患者对如何服用药物和如何支付费用有了更多的控制权。</p>
<p>&#34;这是一个非常以消费者为驱动的市场。这是一种生活方式疾病。保险覆盖并不好，因此很多人最终选择自费，&#34; GoodRx（GDRX）处方节省网站的高级副总裁兼 GLP-1 专家 Divya Iyer 说。&#34;当我们考虑决定谁将成为赢家的因素时，将是价格最实惠的品牌。&#34;</p>
<p>专家指出，这些是长期维持治疗药物。由于患者在停止治疗后往往会重新增重，因此许多人预计会无限期地继续使用这些药物以维持效果。</p>
<p>以下是不同主流减肥药物的价格和支付方式的概述。</p>
<p>注射剂与药丸</p>
<p>患者首先应该检查他们的保险是否覆盖 GLP-1 减肥药物。那些拥有商业保险的人通常可以使用诺和诺德或礼来等制药公司的制造商节省卡，将自付共付费用降低到每月仅 25 美元。</p>
<p>那些没有保险或保险计划不覆盖 GLP-1 减肥药物的人必须寻找制造商直接合作和分级自付计划，以避免注射剂的高昂标价，这些价格可能超过 1000 美元。这些计划可以为精明的自费购物者将这些费用降低多达 70%。</p>
<p>阅读更多：美国有了一种新的减肥药，它是一种药丸</p>
<p>较新的减肥药丸价格稍便宜，因为它们&#34;更容易生产，&#34; Iyer 说。&#34;注射剂必须在较低温度下储存，这增加了成本。&#34;</p>
<p>以下是最受欢迎的 FDA 批准的减肥注射剂和药丸的详细信息。</p>
<p>注射剂：</p>
<p>-- Wegovy 的自动注射器通过特定的现金支付优惠，起价为 199 美元，提供两个月的起始剂量，然后每月跳升至 349 美元。</p>
<p>-- 礼来的 Zepbound 瓶和注射器（单剂量瓶）起价为每月 299 美元，适用于通过直接面向患者的平台如 LillyDirect 的起始剂量。</p>
<p>-- Zepbound 的 KwikPen 是一种多剂量设备，包含一个月的完整治疗，起价为每月 299 美元，适用于起始剂量。</p>
<p>-- Zepbound 的自动注射器，单剂量笔，标价为 1060 美元 - 这是现金支付患者中最昂贵的选择，通常由那些保险计划覆盖大部分费用的人使用。</p>
<p>-- 诺和诺德的新高剂量注射剂 Wegovy HD 的价格也低于礼来的 Zepbound：Wegovy HD 每月 399 美元，而 Zepbound 竞争笔的四个最高剂量为每月 449 美元。</p>
<p>药丸：</p>
<p>-- Wegovy 药丸的价格为每月 149 至 299 美元，具体取决于剂量。</p>
<p>-- Foundayo 的价格范围为每月 149 至 399 美元。</p>
<p>&#34;礼来对 Foundayo 的定价似乎与 Wegovy 药丸相似，但在最高剂量时更高，这在我看来表明他们并不想与诺和诺德或复合药物在美国自费市场上展开价格竞争，&#34; Morningstar Equity Research（MORN）的医疗主管 Karen Andersen 说。</p>
<p>如何找到这些价格 - 并避免意外费用</p>
<p>在 GLP-1 药物上节省费用需要选择正确的平台。TrumpRx 是一个政府运营的平台，于 2 月推出，突出了一些来自制药公司的折扣药物，作为自费患者的联邦中心，为直接从 LillyDirect 等网站购买的患者提供最低价格。像 GoodRx 这样的平台提供了重要的交叉检查，列出了类似的优惠券以及有时能超过联邦价格的单独药房折扣。</p>
<p>阅读更多：是时候重新思考我们如何定义肥胖，因为数百万人转向 GLP-1 药物</p>
<p>一些患者选择通过直接面向消费者的平台如 Hims &amp; Hers Health（HIMS）、Ro 或 Weight Watchers（WW）获取减肥药物。诺和诺德甚至在 3 月底宣布与这些平台合作推出 Wegovy 订阅计划。但请记住，便利是有代价的 - 这些应用程序在用户支付处方费用的基础上还附加了会员费。</p>
<p>Hims &amp; Hers 最近面临来自诺和诺德公司的监管压力和诉讼，原因是其销售未获得 FDA 批准的复合 GLP-1 药物。该公司已与诺和诺德结束争议，现在仅宣传 FDA 批准的产品。根据公司新闻稿，它仍然 “计划在提供者确定复合产品在临床上是必要的情况下，提供复合 GLP-1 的获取。”</p>
<p>专家们敦促患者无论是使用保险的优惠券支付仅 $25，还是获得折扣自付价格，都应仔细阅读细则。一些保险计划不将制造商优惠券计入免赔额，这可能导致年中出现巨额意外账单，KFF 高级政策经理米歇尔·朗表示。</p>
<p>自付费用的患者可能会发现他们的折扣有使用上限或是促销优惠。例如，礼来的条款和条件规定，Foundayo 自付折扣每年只能使用 10 个月。Wegovy 注射笔的特定剂量月费用为 $199，但在两个月后将上涨至 $349。</p>
<p>朗表示：“在一个已经极其复杂、支离破碎且微妙的医疗系统中，有很多附加条件和复杂性。”</p>
<p>接下来阅读：一半的 GLP-1 用户放弃注射——一些人转向其他减肥方法。</p>
<p>您希望在 MarketWatch 中看到哪些个人财务问题的报道？我们希望听到读者关于他们财务决策和与金钱相关问题的反馈。您可以通过 readerstories@marketwatch.com 写信给我们。记者可能会联系您以了解更多信息。MarketWatch 不会在未获得您许可的情况下将您的答案以姓名归属。</p>
<p>-Genna Contino</p>
<p>此内容由 MarketWatch 创建，MarketWatch 由道琼斯公司运营。MarketWatch 独立于道琼斯新闻通讯和华尔街日报发布。</p>
<p>（结束）道琼斯新闻通讯</p>
<p>04-09-26 1337ET</p>

2 倍做多 LLY ETF - Direxion

诺和诺德公司

礼来

<p>GLP-1 减肥药物的成本显著下降，包括 Wegovy 和 Zepbound，价格现在低至 149 美元的药片和 199 美元的注射剂。诺和诺德公司和礼来是这一不断扩大的市场的主要参与者，诺和诺德公司提供了更具价格竞争力的选择。然而，保险覆盖范围仍然有限，迫使许多患者自掏腰包。市场以消费者为驱动，患者寻求最佳价格和长期维持药物的选择。文章提供了各种 GLP-1 药物及其定价的详细信息</p>

<p>By Genna Contino</p>
<div class="lb-trans"><p>作者：Genna Contino</p>
</div><p>As a new weight-loss pill and high-dose injection enter the market, costs have plummeted to a fraction of their original price</p>
<div class="lb-trans"><p>随着一种新的减肥药丸和高剂量注射剂进入市场，价格已降至原价的一小部分</p>
</div><p>GLP-1 drugs now come in injectables and pills - but figuring out how to pay for them can get complicated.</p>
<div class="lb-trans"><p>GLP-1 药物现在有注射剂和药丸形式，但如何支付这些药物的费用可能会变得复杂。</p>
</div><p>Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose among different types of injectables and even pills, with discounted cash prices dipping as low as $149.</p>
<div class="lb-trans"><p>以前，使用 GLP-1 药物意味着每月注射一次，费用高达 1000 美元。如今，想要使用这种广受欢迎的减肥药物的患者可以选择不同类型的注射剂甚至药丸，现金折扣价格低至 149 美元。</p>
</div><p>The market for weight-loss medications is still expanding, too. Drugmaker Novo Nordisk (NVO) announced Tuesday that a higher dosage of its Wegovy injectable is now available in the U.S., adding another option to the marketplace just a week after the Food and Drug Administration approved Foundayo, a weight-loss pill developed by competitor Eli Lilly (LLY).</p>
<div class="lb-trans"><p>减肥药物市场仍在扩张。制药公司诺和诺德（Novo Nordisk）周二宣布，其 Wegovy 注射剂的更高剂量现在在美国上市，成为市场上的另一个选择，仅在食品和药物管理局批准竞争对手礼来的（Eli Lilly）减肥药 Foundayo 一周后。</p>
</div><p>Figuring out how to pay for these drugs can be complicated, and it's a key issue for consumers as healthcare costs and insurance premiums soar.</p>
<div class="lb-trans"><p>如何支付这些药物的费用可能很复杂，这也是消费者面临的一个关键问题，因为医疗费用和保险费飙升。</p>
</div><p>Just 19% of commercial insurance plans offered by companies with 200 or more employees covered GLP-1 drugs for weight loss in 2025, according to a health-benefits survey from KFF, a nonpartisan health-policy research, polling and news organization - and when they do, they often come with restrictions. That means many patients are forced to pay out of pocket or seek out manufacturer coupons to help ease the cost burden.</p>
<div class="lb-trans"><p>根据 KFF 的健康福利调查，2025 年，拥有 200 名或更多员工的公司提供的商业保险计划中，仅有 19% 计划覆盖 GLP-1 减肥药物，而且即使覆盖，通常也会附带限制。这意味着许多患者被迫自费或寻找制造商优惠券以减轻费用负担。</p>
</div><p>Read more: The new high dose of Wegovy costs less than Zepbound</p>
<div class="lb-trans"><p>阅读更多：新的高剂量 Wegovy 的价格低于 Zepbound</p>
</div><p>Healthcare analysts say Novo Nordisk has made the most effort to provide affordable obesity treatment options for self-paying patients, in part because Lilly's drugs have the most market share, but price points for medications from both companies remain largely similar. As new options pop up, patients have more control over how they take the medication and how they pay for it.</p>
<div class="lb-trans"><p>医疗分析师表示，诺和诺德在为自费患者提供可负担的肥胖治疗选择方面做出了最大努力，部分原因是礼来的药物市场份额最大，但两家公司药物的价格点大致相似。随着新选择的出现，患者对如何服用药物和如何支付费用有了更多的控制权。</p>
</div><p>&#34;This is a very consumer-driven market. It's a lifestyle condition. Insurance coverage isn't great, and so a lot of people end up choosing to just pay out of pocket,&#34; said Divya Iyer, senior vice president and resident GLP-1 expert at prescription-savings website GoodRx (GDRX). &#34;When we think about what determines who the winner will be, it will be the brand that has the most affordable price.&#34;</p>
<div class="lb-trans"><p>&#34;这是一个非常以消费者为驱动的市场。这是一种生活方式疾病。保险覆盖并不好，因此很多人最终选择自费，&#34; GoodRx（GDRX）处方节省网站的高级副总裁兼 GLP-1 专家 Divya Iyer 说。&#34;当我们考虑决定谁将成为赢家的因素时，将是价格最实惠的品牌。&#34;</p>
</div><p>Experts note that these are long-term maintenance medications. Because patients often regain weight after stopping treatment, many are expected to stay on the drugs indefinitely in order to maintain their results.</p>
<div class="lb-trans"><p>专家指出，这些是长期维持治疗药物。由于患者在停止治疗后往往会重新增重，因此许多人预计会无限期地继续使用这些药物以维持效果。</p>
</div><p>Here's a look at the different mainstream weight-loss drugs, their price points and how to pay for them.</p>
<div class="lb-trans"><p>以下是不同主流减肥药物的价格和支付方式的概述。</p>
</div><p>Injectables vs. pills</p>
<div class="lb-trans"><p>注射剂与药丸</p>
</div><p>The first thing patients should check is if their insurance covers GLP-1 drugs for weight loss. Those who have commercial coverage can often use a manufacturer savings card from drugmakers like Novo Nordisk or Eli Lilly to lower the out-of-pocket co-pay to as little as $25 per month.</p>
<div class="lb-trans"><p>患者首先应该检查他们的保险是否覆盖 GLP-1 减肥药物。那些拥有商业保险的人通常可以使用诺和诺德或礼来等制药公司的制造商节省卡，将自付共付费用降低到每月仅 25 美元。</p>
</div><p>Those who are uninsured or have plans that don't cover GLP-1s for weight loss have to look into manufacturer-direct partnerships and tiered self-pay programs to avoid the eye-popping list prices for injectables, which can top $1,000. These programs can cut those costs by up to 70% for savvy self-paying shoppers.</p>
<div class="lb-trans"><p>那些没有保险或保险计划不覆盖 GLP-1 减肥药物的人必须寻找制造商直接合作和分级自付计划，以避免注射剂的高昂标价，这些价格可能超过 1000 美元。这些计划可以为精明的自费购物者将这些费用降低多达 70%。</p>
</div><p>Read more: America has a new weight-loss drug, and it's a pill</p>
<div class="lb-trans"><p>阅读更多：美国有了一种新的减肥药，它是一种药丸</p>
</div><p>The newer weight-loss pills are a bit cheaper, because they &#34;are easier to produce,&#34; Iyer said. &#34;The injections have to be stored at a lower temperature, which drives up costs.&#34;</p>
<div class="lb-trans"><p>较新的减肥药丸价格稍便宜，因为它们&#34;更容易生产，&#34; Iyer 说。&#34;注射剂必须在较低温度下储存，这增加了成本。&#34;</p>
</div><p>Here's a breakdown of the most popular FDA-approved injectables and pills for weight loss.</p>
<div class="lb-trans"><p>以下是最受欢迎的 FDA 批准的减肥注射剂和药丸的详细信息。</p>
</div><p>Injectables:</p>
<div class="lb-trans"><p>注射剂：</p>
</div><p>-- Wegovy's auto-injector starts at $199 for two months of starter doses through specific introductory cash-pay offers, then jumps to $349 per month.</p>
<div class="lb-trans"><p>-- Wegovy 的自动注射器通过特定的现金支付优惠，起价为 199 美元，提供两个月的起始剂量，然后每月跳升至 349 美元。</p>
</div><p>-- Lilly's Zepbound vial and syringe (single-dose vials) starts at $299 per month for the starter dose via direct-to-patient platforms like LillyDirect.</p>
<div class="lb-trans"><p>-- 礼来的 Zepbound 瓶和注射器（单剂量瓶）起价为每月 299 美元，适用于通过直接面向患者的平台如 LillyDirect 的起始剂量。</p>
</div><p>-- Zepbound's KwikPen, which is a multidose device containing a full month of treatment in a single pen, also starts at $299 per month for the starter dose.</p>
<div class="lb-trans"><p>-- Zepbound 的 KwikPen 是一种多剂量设备，包含一个月的完整治疗，起价为每月 299 美元，适用于起始剂量。</p>
</div><p>-- Zepbound's auto-injector, a single-dose pen, has a list price of $1,060 - the most expensive option for cash-paying patients that's typically used by those with insurance plans that cover most of the cost.</p>
<div class="lb-trans"><p>-- Zepbound 的自动注射器，单剂量笔，标价为 1060 美元 - 这是现金支付患者中最昂贵的选择，通常由那些保险计划覆盖大部分费用的人使用。</p>
</div><p>-- Novo Nordisk also has a cheaper price than Lilly for its new high-dose injectable: Wegovy HD costs $399 per month, while the four highest dosages of Zepbound's competing pen are $449 per month.</p>
<div class="lb-trans"><p>-- 诺和诺德的新高剂量注射剂 Wegovy HD 的价格也低于礼来的 Zepbound：Wegovy HD 每月 399 美元，而 Zepbound 竞争笔的四个最高剂量为每月 449 美元。</p>
</div><p>Pills:</p>
<div class="lb-trans"><p>药丸：</p>
</div><p>-- The Wegovy pill costs $149 to $299 per month, depending on dosage.</p>
<div class="lb-trans"><p>-- Wegovy 药丸的价格为每月 149 至 299 美元，具体取决于剂量。</p>
</div><p>-- Foundayo's price ranges from $149 to $399 per month.</p>
<div class="lb-trans"><p>-- Foundayo 的价格范围为每月 149 至 399 美元。</p>
</div><p>&#34;Lilly's pricing for Foundayo appears similar to Wegovy pill but higher at the highest doses, which to me says that they aren't interested in getting into a price battle with Novo or compounders to win oral patients in the U.S. self-pay market,&#34; said Karen Andersen, healthcare director at Morningstar Equity Research (MORN).</p>
<div class="lb-trans"><p>&#34;礼来对 Foundayo 的定价似乎与 Wegovy 药丸相似，但在最高剂量时更高，这在我看来表明他们并不想与诺和诺德或复合药物在美国自费市场上展开价格竞争，&#34; Morningstar Equity Research（MORN）的医疗主管 Karen Andersen 说。</p>
</div><p>How to find those prices - and not get hit with surprise charges</p>
<div class="lb-trans"><p>如何找到这些价格 - 并避免意外费用</p>
</div><p>Saving on GLP-1s requires choosing the right portal. TrumpRx, a government-operated platform launched in February that highlights some discounted medications from drugmakers, serves as a federal hub for self-paying patients, offering the lowest rates for those who buy directly from sites like LillyDirect. Platforms like GoodRx provide a vital cross-check, listing similar coupons alongside separate pharmacy discounts that can sometimes beat federal rates.</p>
<div class="lb-trans"><p>在 GLP-1 药物上节省费用需要选择正确的平台。TrumpRx 是一个政府运营的平台，于 2 月推出，突出了一些来自制药公司的折扣药物，作为自费患者的联邦中心，为直接从 LillyDirect 等网站购买的患者提供最低价格。像 GoodRx 这样的平台提供了重要的交叉检查，列出了类似的优惠券以及有时能超过联邦价格的单独药房折扣。</p>
</div><p>Read more: It's time to rethink how we define obesity as millions turn to GLP-1s</p>
<div class="lb-trans"><p>阅读更多：是时候重新思考我们如何定义肥胖，因为数百万人转向 GLP-1 药物</p>
</div><p>Some patients have opted to get weight-loss medications from direct-to-consumer platforms like Hims &amp; Hers Health (HIMS), Ro or Weight Watchers (WW). Novo Nordisk even announced a Wegovy subscription program with these platforms at the end of March. But keep in mind that convenience comes at a cost - these apps have membership fees tacked on top of what users pay for a prescription.</p>
<div class="lb-trans"><p>一些患者选择通过直接面向消费者的平台如 Hims &amp; Hers Health（HIMS）、Ro 或 Weight Watchers（WW）获取减肥药物。诺和诺德甚至在 3 月底宣布与这些平台合作推出 Wegovy 订阅计划。但请记住，便利是有代价的 - 这些应用程序在用户支付处方费用的基础上还附加了会员费。</p>
</div><p>Hims &amp; Hers recently faced regulatory pressure and a lawsuit from Novo Nordisk for selling compounded GLP-1 drugs that are not FDA-approved. The company has since ended the dispute with Novo Nordisk and now only advertises FDA-approved products. It still &#34;plans to offer access to compounded GLP-1s if a provider determines that a compounded product is clinically necessary,&#34; according to a company news release.</p>
<div class="lb-trans"><p>Hims &amp; Hers 最近面临来自诺和诺德公司的监管压力和诉讼，原因是其销售未获得 FDA 批准的复合 GLP-1 药物。该公司已与诺和诺德结束争议，现在仅宣传 FDA 批准的产品。根据公司新闻稿，它仍然 “计划在提供者确定复合产品在临床上是必要的情况下，提供复合 GLP-1 的获取。”</p>
</div><p>Whether they're paying just $25 using a coupon with insurance or getting a discounted self-pay price, patients should read the fine print, experts urge. Some insurance plans don't count manufacturer coupons toward a deductible, which can lead to a massive surprise bill mid-year, said KFF senior policy manager Michelle Long.</p>
<div class="lb-trans"><p>专家们敦促患者无论是使用保险的优惠券支付仅 $25，还是获得折扣自付价格，都应仔细阅读细则。一些保险计划不将制造商优惠券计入免赔额，这可能导致年中出现巨额意外账单，KFF 高级政策经理米歇尔·朗表示。</p>
</div><p>Those paying out of pocket might find that their discounts have usage caps or introductory offers. For example, Lilly's terms and conditions specify that Foundayo self-pay discounts can only be used 10 months per year. The Wegovy injectable pen is advertised at a monthly cost of $199 for specific dosages, but that jumps to $349 after two months.</p>
<div class="lb-trans"><p>自付费用的患者可能会发现他们的折扣有使用上限或是促销优惠。例如，礼来的条款和条件规定，Foundayo 自付折扣每年只能使用 10 个月。Wegovy 注射笔的特定剂量月费用为 $199，但在两个月后将上涨至 $349。</p>
</div><p>&#34;There's a lot of caveats, a lot of complexity in an already extremely complex, fragmented and nuanced healthcare system,&#34; Long said.</p>
<div class="lb-trans"><p>朗表示：“在一个已经极其复杂、支离破碎且微妙的医疗系统中，有很多附加条件和复杂性。”</p>
</div><p>Read next: Half of GLP-1 users ditch their injections - and some are turning to other weight-loss methods instead</p>
<div class="lb-trans"><p>接下来阅读：一半的 GLP-1 用户放弃注射——一些人转向其他减肥方法。</p>
</div><p>What personal-finance issues would you like to see covered in MarketWatch? We would like to hear from readers about their financial decisions and money-related questions. You can write to us at readerstories@marketwatch.com. A reporter may be in touch to learn more. MarketWatch will not attribute your answers to you by name without your permission.</p>
<div class="lb-trans"><p>您希望在 MarketWatch 中看到哪些个人财务问题的报道？我们希望听到读者关于他们财务决策和与金钱相关问题的反馈。您可以通过 readerstories@marketwatch.com 写信给我们。记者可能会联系您以了解更多信息。MarketWatch 不会在未获得您许可的情况下将您的答案以姓名归属。</p>
</div><p>-Genna Contino</p>
<div class="lb-trans"><p>-Genna Contino</p>
</div><p>This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.</p>
<div class="lb-trans"><p>此内容由 MarketWatch 创建，MarketWatch 由道琼斯公司运营。MarketWatch 独立于道琼斯新闻通讯和华尔街日报发布。</p>
</div><p>(END) Dow Jones Newswires</p>
<div class="lb-trans"><p>（结束）道琼斯新闻通讯</p>
</div><p>04-09-26 1337ET</p>
<div class="lb-trans"><p>04-09-26 1337ET</p>
</div>

以下是减肥药物 Wegovy、Zepbound 和 Foundayo 的价格，以及如何选择最适合您的 GLP-1 药物